NGS-based RNA-seq

Global Market Trajectory & Analytics

MCP13599

EXECUTIVE ENGAGEMENTS

OUTREACH

3213
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

579
Interactions with Platform & by Email

PARTICIPANTS

96
Unique # Participated

VALIDATIONS

28
Responses Validated*

COMPETITORS

46
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

142

PAGES

218

EDITION

9

PRICE

USD 5450

  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.
The NGS-based RNA-seq market in the U.S. is estimated at US$438 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$918.6 Million by the year 2027 trailing a CAGR of 19.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.
In the global RNA Sequencing Services segment, USA, Canada, Japan, China and Europe will drive the 20% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$284 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$654.6 Million by the year 2027.

SELECT PLAYERS

Agilent Technologies, Inc.; Eurofins Scientific; F. Hoffmann-La Roche AG; GATC Biotech AG; Illumina, Inc.; Macrogen, Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California, Inc.; PerkinElmer, Inc.; Qiagen NV; Thermo Fisher Scientific, Inc.

SEGMENTS

» Application (De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics, Small RNA Sequencing) » End-Use (Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses) » Products & Services (Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services, Data Analysis, Storage, and Management) » Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing, Nanopore Sequencing)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
RNA-Seq: An Introduction
A Prelude to NGS-based RNA-seq Market
North America: The Largest Market for NGS-based RNA-seq
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
NGS-based RNA-seq Market Drivers and Restraints
Recent Advances in RNA Sequence Analysis
Select Players of NGS-based RNA-seq Market
Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique
Application of RNA-Seq in Precision Medicine
Next Generation Sequencing in Cancer Research
Next Generation Sequencing for Transcriptomic Profiling
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for NGS-based RNA-seq by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for NGS-based RNA-seq by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Sequencing Platforms & Consumables for RNA-Seq by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Sequencing Platforms & Consumables for RNA-Seq by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for RNA Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for RNA Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Data Analysis, Storage, and Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Data Analysis, Storage, and Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Sequencing by Synthesis (SBS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Sequencing by Synthesis (SBS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Ion Semiconductor Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Ion Semiconductor Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for De Novo Transcriptome Assembly by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for De Novo Transcriptome Assembly by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Expression Profiling Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Expression Profiling Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Variant Calling and Transcriptome Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Variant Calling and Transcriptome Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Small RNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Small RNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Research Centers & Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Research Centers & Academic & Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
USA Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
USA Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
USA Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
USA Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Canada Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Canada Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Canada Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Japan Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Japan Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Japan Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
CHINA
China Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
China Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
China Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
China Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for NGS-based RNA-seq by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for NGS-based RNA-seq by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Europe Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Europe Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Europe Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
France Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
France Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
France Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Germany Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Germany Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Germany Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Italy Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Italy Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Italy Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
UK Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
UK Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
UK Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for NGS-based RNA-seq by Products & Services - Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for NGS-based RNA-seq by Products & Services - Percentage Breakdown of Value Sales for Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services and Data Analysis, Storage, and Management for the Years 2020 & 2027
Rest of World Current & Future Analysis for NGS-based RNA-seq by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for NGS-based RNA-seq by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2020 & 2027
Rest of World Current & Future Analysis for NGS-based RNA-seq by Application - De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for NGS-based RNA-seq by Application - Percentage Breakdown of Value Sales for De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics and Small RNA Sequencing for the Years 2020 & 2027
Rest of World Current & Future Analysis for NGS-based RNA-seq by End-Use - Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for NGS-based RNA-seq by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End-Uses for the Years 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 46

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com